Evergreen Theragnostics Completes $19 Million Series A Capital Raise

JERSEY CITY, N.J., June 22, 2020 /PRNewswire/ -- Evergreen Theragnostics, Inc., a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced that it has raised $19M in a Series A financing round. The investment was made by private investors in common shares of the company.
（以上内容由医药魔方AI生成）